Jacqueline Palace Selected Research

Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)

1/2021	Presynaptic congenital myasthenic syndrome due to three novel mutations in SLC5A7 encoding the sodium-dependant high-affinity choline transporter.
1/2020	Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure.
12/2019	β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
12/2015	Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
9/2015	Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes.
9/2015	Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
11/2014	Inherited disorders of the neuromuscular junction: an update.
10/2014	Congenital myasthenic syndromes and the neuromuscular junction.
3/2013	Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
2/2013	Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacqueline Palace Research Topics

Disease

46	Neuromyelitis Optica (Devic's Disease) 02/2022 - 04/2007
34	Multiple Sclerosis 02/2022 - 12/2003
12	Transverse Myelitis (Necrotizing Myelitis) 05/2022 - 04/2007
11	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2021 - 06/2007
10	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 12/2009
6	Inflammation (Inflammations) 02/2022 - 04/2015
5	Myasthenia Gravis 09/2022 - 06/2015
5	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 01/2015
5	Relapsing-Remitting Multiple Sclerosis 04/2021 - 05/2015
5	Pain (Aches) 01/2021 - 09/2016
5	Fatigue 01/2020 - 01/2010
3	Ganglion Cysts (Ganglion) 11/2021 - 12/2018
3	Infections 01/2021 - 01/2018
3	Myelitis 01/2020 - 08/2015
3	Muscle Weakness 12/2019 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 04/2007
3	Atrophy 11/2019 - 01/2013
2	Cognitive Dysfunction 01/2022 - 11/2014
2	Spontaneous Abortion (Miscarriage) 01/2022 - 01/2021
2	Neurosarcoidosis 07/2021 - 01/2020
2	Paralysis (Palsy) 07/2021 - 01/2018
2	Optic Nerve Diseases (Optic Neuropathy) 07/2021 - 12/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 01/2019
2	Headache (Headaches) 05/2021 - 01/2019
2	Thymoma (Thymic Carcinoma) 01/2020 - 01/2018
2	Chronic Disease (Chronic Diseases) 11/2019 - 01/2019
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 10/2019 - 11/2013
2	Chronic Progressive Multiple Sclerosis 10/2014 - 01/2013
2	Disease Progression 01/2013 - 07/2012
2	Sleepiness 07/2012 - 01/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2012 - 07/2011
1	Mononeuropathies (Mononeuritis Multiplex) 07/2021
1	Hydrocephalus (Hydrocephaly) 07/2021
1	Nasopharyngitis 05/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Arteriolosclerosis 10/2020
1	Cerebral Small Vessel Diseases 10/2020
1	Lymphocytosis 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2019
1	Muscle Hypotonia (Hypotonia) 01/2019

Drug/Important Bio-Agent (IBA)

32	AntibodiesIBA 08/2021 - 02/2004
19	Myelin-Oligodendrocyte GlycoproteinIBA 05/2022 - 09/2012
13	AutoantibodiesIBA 01/2022 - 02/2004
12	Immunoglobulin G (IgG)IBA 01/2022 - 02/2004
9	anti-aquaporin 4 autoantibodyIBA 01/2021 - 11/2013
8	Aquaporins (Water Channels)IBA 01/2022 - 01/2016
8	Aquaporin 4IBA 06/2021 - 04/2007
8	Cholinergic ReceptorsIBA 01/2020 - 06/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
6	eculizumab FDA Link 01/2022 - 01/2019
6	Retinaldehyde (Retinal)IBA 01/2022 - 12/2018
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2014
5	Rituximab (Mabthera)FDA Link 09/2022 - 03/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 12/2003
4	Glatiramer Acetate (Copaxone)FDA Link 01/2019 - 01/2014
4	Interferon-betaIBA 01/2019 - 08/2010
4	AntigensIBA 01/2017 - 02/2004
3	Azathioprine (Imuran)FDA LinkGeneric 07/2021 - 03/2014
3	Oligoclonal BandsIBA 01/2021 - 01/2015
3	muskIBA 01/2020 - 01/2018
3	Albuterol (Salbutamol)FDA LinkGeneric 12/2019 - 02/2013
3	Amiloride (Midamor)FDA LinkGeneric 01/2019 - 01/2013
2	Formaldehyde (Formol)FDA Link 02/2022 - 10/2020
2	Complement System Proteins (Complement)IBA 02/2022 - 01/2021
2	ParaffinIBA 02/2022 - 10/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2021
2	SteroidsIBA 01/2022 - 07/2021
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 04/2015
2	IronIBA 01/2022 - 07/2011
2	Inositol (Myoinositol)IBA 01/2021 - 08/2013
2	satralizumabIBA 01/2021 - 11/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2019 - 01/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 01/2018
2	Acid Sensing Ion ChannelsIBA 01/2019 - 01/2013
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2018 - 01/2018
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2014 - 03/2013
2	Lipoproteins (Lipoprotein)IBA 11/2014 - 10/2014
2	InterferonsIBA 01/2014 - 10/2012
2	Neuroprotective AgentsIBA 01/2013 - 07/2012
2	Modafinil (Provigil)FDA Link 07/2012 - 01/2010
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2021
1	Infliximab (Remicade)FDA Link 07/2021
1	Methotrexate (Mexate)FDA LinkGeneric 07/2021
1	Prednisolone (Predate)FDA LinkGeneric 07/2021
1	Complement Inactivating AgentsIBA 05/2021
1	Biological ProductsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	inebilizumabIBA 01/2021
1	SodiumIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	choline transporterIBA 01/2021
1	VS 215IBA 11/2019
1	FlavonoidsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2010
2	Immunotherapy 07/2021 - 01/2016
1	Cesarean Section (Caesarean Section) 01/2022
1	Thymectomy 01/2020
1	Nutritional Support (Artificial Feeding) 01/2019